The latest biotech news

News and Trends 6 Dec 2022

INSPIRE launched to develop inhaled gene therapy for the treatment of lung cancer

OmniSpirant Limited and EVerZom have launched INSPIRE, a €12.8 million ($13.4 million) lung cancer project funded by Horizon Europe. In one of the largest ever grants for preclinical research in lung cancer, OmniSpirant and its European partners in biotechnology, medical devices, cancer research, academia and patient advocacy, met in Galway, Ireland, for the official kick-off […]

December 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

Entact Bio launches with $81M to develop precision medicines

Entact Bio has raised $81 million in series A financing to advance its proprietary Encompass platform for developing enhancement-targeting chimeric (ENTAC) molecules. The round was co-led by Qiming Venture Partners USA and venBio Partners, with participation by new investors Abingworth, Brandon Capital, Janus Henderson Investors, Logos Capital, Surveyor Capital (a Citadel company), and WEHI (Walter […]

December 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

Avalon BioVentures to invest in early-stage biotech

L.P., a venture capital firm dedicated to early-stage biomedical innovation, has closed its first venture fund, ABV1, with $135 million in funding from new and existing institutional investors. Avalon BioVentures emerged from Avalon Ventures’ shared life-science/high-tech investing funds as a life-science only fund and will continue to leverage Avalon’s team and company accelerator to create, […]

December 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

Pictor receives $5M in funding for Covid antibody test and human and animal portfolios

Pictor, a global leader in immunodiagnostics, has announced a $5 million funding round to help accelerate pipeline product development projects. The company will also use the funding for market development activities within Australia and New Zealand, the U.S. and Europe for its human health and animal health portfolios. This follows a June funding round raising […]

December 6, 2022 - 3 minutesmins - By Liza Laws

News and Trends 6 Dec 2022

New brain tumor subtypes discovery may help develop treatments for incurable brain cancer

Research led by RCSI University of Medicine and Health Sciences in Ireland has discovered three new subtypes of brain tumor. This could help to identify new and effective therapies. The novel tumor subtypes are forms of glioblastoma, the most common and most aggressive form of adult primary brain cancer with no cure currently available. The […]

December 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

ImaginAb launching clinical trial for renal cancer and malignant melanoma

ImaginAb Inc., which is focused on developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET) imaging agent and radiopharmaceutical therapy (RPT) products, is starting a phase II clinical trial. The trial, PRETZCEL, which will take place at Hull University Teaching Hospitals NHS Trust in the U.K., will investigate ImaginAb’s investigational CD8 ImmunoPET agent in patients with melanoma or […]

December 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

Positive results from BioAge muscle atrophy trial

BioAge Labs, Inc. has announced positive phase 1b clinical data for BGE-105, a highly selective, potent, orally available small-molecule agonist of the apelin receptor APJ. BGE-105 treatment resulted in statistically significant prevention of muscle atrophy relative to placebo in healthy volunteers aged 65 or older after 10 days of strict bed rest. Muscle atrophy—loss of […]

December 6, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

Startup Graegis developing therapies for radiation side-effects

Graegis Pharmaceuticals, a startup developing new therapies aimed at preventing the side effects of radiotherapies, is set to complete the regulatory nonclinical package allowing entry in clinical trials. The company, founded in the last quarter of 2021, spent the first year of operations running critical experiments on the new therapies, which will target radiation side […]

December 6, 2022 - 2 minutesmins - By Liza Laws

News and Trends 5 Dec 2022

Positive antibody persistence for vaccine treating mosquito disease

A single shot vaccine for mosquito-borne disease chikungunya has had positive antibody persistence data 12 months after vaccination. The primary endpoint also met with a 99% seroresponse rate. The disease is caused by the chikungunya virus (CHIKV), a Togaviridae virus, transmitted by Aedes mosquitoes. Following positive immunogenicity and safety data from a phase 3 study […]

December 5, 2022 - 3 minutesmins - By Liza Laws

News and Trends 5 Dec 2022

Fallouh Healthcare’s device to give early diagnosis for post-surgery strangulation risk

U.K.-based Fallouh Healthcare is developing a device to monitor cardiac patients after surgery, which is when a condition, called cardiac tamponade, can strike. The company says patients recovering from heart surgery can be at risk from the life-threatening condition that sees fluid build-up around the heart, strangling its ability to beat properly. Fallouh Healthcare, formed […]

December 5, 2022 - 3 minutesmins - By Liza Laws

News and Trends 5 Dec 2022

New company Liminatus Pharma Inc to develop three cancer treatments

Clinical-stage biopharma company Liminatus Pharma LLC and Iris Acquisition Corp, a publicly traded special purpose acquisition company formed for the purpose of acquiring or merging with one or more businesses, announced they have entered into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed Liminatus Pharma, Inc.. The […]

December 5, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Dec 2022

Singapore researchers develop affordable cancer testing method

Scientists from the National University of Singapore (NUS) have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, the new test sequences clinical samples that have been heated in order to isolate cancer-specific signatures found in a patient’s blood. The new method provides a promising non-invasive alternative to tissue biopsies. It […]

December 5, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

INSPIRE launched to develop inhaled gene therapy for the treatment of lung cancer

Entact Bio launches with $81M to develop precision medicines

Avalon BioVentures to invest in early-stage biotech

Pictor receives $5M in funding for Covid antibody test and human and animal portfolios

New brain tumor subtypes discovery may help develop treatments for incurable brain cancer

ImaginAb launching clinical trial for renal cancer and malignant melanoma

Positive results from BioAge muscle atrophy trial

Startup Graegis developing therapies for radiation side-effects

Positive antibody persistence for vaccine treating mosquito disease

Fallouh Healthcare’s device to give early diagnosis for post-surgery strangulation risk

New company Liminatus Pharma Inc to develop three cancer treatments

Singapore researchers develop affordable cancer testing method

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!